Your browser doesn't support javascript.
loading
Lipid profiling as an effective approach for identifying biomarkers/adverse events associated with pediatric anesthesia.
Wang, Cheng; Han, Xianlin; Liu, Fang; Patterson, Tucker A; Hanig, Joseph P; Paule, Merle G; Slikker, William.
Afiliación
  • Wang C; Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: cheng.wang@fda.hhs.gov.
  • Han X; Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona, Orlando, FL 32827, USA.
  • Liu F; Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.
  • Patterson TA; National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.
  • Hanig JP; Center for Drug Evaluation and Research/Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Paule MG; Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.
  • Slikker W; National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.
Toxicol Appl Pharmacol ; 354: 191-195, 2018 09 01.
Article en En | MEDLINE | ID: mdl-29550513
Adverse effects related to central nervous system (CNS) function in pediatric populations may, at times, be difficult, if not impossible to evaluate. Prolonged anesthetic exposure affects brain excitability and anesthesia during the most sensitive developmental stages and has been associated with mitochondrial dysfunction, aberrant lipid metabolism and synaptogenesis, subsequent neuronal damage, as well as long-term behavioral deficits. There has been limited research evaluating whether and how anesthetic agents affect cellular lipids, the most abundant components of the brain other than water. Therefore, this review discusses: (1) whether the observed anesthetic-induced changes in lipid profiles seen in preclinical studies represents early signs of neurotoxicity; (2) the potential mechanisms underlying anesthetic-induced brain injury; and (3) whether lipid biomarker(s) identified in preclinical studies can serve as markers for the early clinical detection of anesthetic-induced neurotoxicity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Síndromes de Neurotoxicidad / Metabolismo de los Lípidos / Metabolómica / Anestesia / Anestésicos / Lípidos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Animals / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Toxicol Appl Pharmacol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Síndromes de Neurotoxicidad / Metabolismo de los Lípidos / Metabolómica / Anestesia / Anestésicos / Lípidos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Animals / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Toxicol Appl Pharmacol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos